UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Should we abandon the APTT for monitoring unfractionated heparin?

Thrombosis research, 2017-09, Vol.157, p.157-161

2017

Link zum Volltext

Verfügbarkeit prüfen

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2015-07, Vol.13 (7), p.1264-1273

2015

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism

Journal of thrombosis and haemostasis, 2016-11, Vol.14 (11), p.2177-2186

2016

Link zum Volltext

Verfügbarkeit prüfen

Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2014-11, Vol.12 (11), p.1801-1809

2014

Link zum Volltext

Verfügbarkeit prüfen

Choosing and using non-steroidal anti-inflammatory drugs in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-03, Vol.22 (2), p.179-187

2016

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome

Thrombosis research, 2018-10, Vol.170, p.60-68

2018

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism

Thrombosis research, 2015-02, Vol.135 (2), p.388-393

2015

Link zum Volltext

Verfügbarkeit prüfen

Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease

International journal of laboratory hematology, 2015-08, Vol.37 (4), p.e75-e77

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience

Thrombosis research, 2016-11, Vol.147, p.32-35

2016

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

The Lancet. Haematology, 2016-09, Vol.3 (9), p.e426-e436

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparative sensitivity of commonly used thromboplastins to ex vivo therapeutic rivaroxaban levels

Thrombosis and haemostasis, 2014-08, Vol.112 (2), p.421

2014

Link zum Volltext

Verfügbarkeit prüfen

P1747Heparin anti-Xa assay versus Activated Partial Thromboplastin Time to monitor unfractionated heparin during Extra-Corporeal-Membrane-Oxygenation

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease

International journal of laboratory hematology, 2015, Vol.37 (4), p.e75-e77

2015

Link zum Volltext

Verfügbarkeit prüfen

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2016-08, Vol.14 (8), p.1673-1676

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Thrombotic Complications in ICU-Treated Patients With Coronavirus Disease 2019 Detected With Systematic CT Scanning

Critical care medicine, 2021-05, Vol.49 (5), p.804

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH: reply

Journal of thrombosis and haemostasis, 2017-01, Vol.15 (1), p.195-197

2017

Link zum Volltext

Verfügbarkeit prüfen

Long‐term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation – single unit dominance is not always the case

British journal of haematology, 2010-04, Vol.149 (2), p.298-299

2010

Link zum Volltext

Verfügbarkeit prüfen

P1718Veno-arterial ECMO versus Left Impella bleeding complications in cardiogenic shock patients on dual antiplatelet therapy

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation--single unit dominance is not always the case

British journal of haematology, 2010, Vol.149 (2), p.298-299

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)
Berichte
(2)

Sprache

Englisch
(19)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Should we abandon the APTT for monitoring unfractionated heparin?

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism

Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome

Choosing and using non-steroidal anti-inflammatory drugs in haemophilia

Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism

Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease

Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

Comparative sensitivity of commonly used thromboplastins to ex vivo therapeutic rivaroxaban levels

P1747Heparin anti-Xa assay versus Activated Partial Thromboplastin Time to monitor unfractionated heparin during Extra-Corporeal-Membrane-Oxygenation

Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH

Prevalence of Thrombotic Complications in ICU-Treated Patients With Coronavirus Disease 2019 Detected With Systematic CT Scanning

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH: reply

Long‐term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation – single unit dominance is not always the case

P1718Veno-arterial ECMO versus Left Impella bleeding complications in cardiogenic shock patients on dual antiplatelet therapy

Long-term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation--single unit dominance is not always the case

Suchergebnisse filtern